Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and metformin in a retrospective Danish nationwide study

@article{Mogensen2014SulfonylureaIC,
  title={Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and metformin in a retrospective Danish nationwide study},
  author={Ulrik Madvig Mogensen and Charlotte Andersson and Emil Loldrup Fosb\ol and Tina Ken Schramm and Allan Vaag and Nikolai Madrid Scheller and C Torp-Pedersen and Gunnar Hilmar Gislason and Lars Valeur K\ober},
  journal={Diabetologia},
  year={2014},
  volume={58},
  pages={50-58}
}
Individual sulfonylureas (SUs) and metformin have, in some studies, been associated with unequal hypoglycaemic, cardiovascular and mortality risks when used as monotherapy in type 2 diabetes. We investigated the outcomes in patients treated with different combinations of SUs and insulin vs a combination of metformin and insulin in a retrospective nationwide… CONTINUE READING